X-71147819-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_181303.2(NLGN3):​c.70C>T​(p.Leu24Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 111,987 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 22)

Consequence

NLGN3
NM_181303.2 missense

Scores

4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.40
Variant links:
Genes affected
NLGN3 (HGNC:14289): (neuroligin 3) This gene encodes a member of a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. Mutations in this gene may be associated with autism and Asperger syndrome. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NLGN3. . Gene score misZ 4.206 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked complex neurodevelopmental disorder, autism, susceptibility to, X-linked 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.09091583).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NLGN3NM_181303.2 linkuse as main transcriptc.70C>T p.Leu24Phe missense_variant 2/8 ENST00000358741.4 NP_851820.1 Q9NZ94-1X5DNV3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NLGN3ENST00000358741.4 linkuse as main transcriptc.70C>T p.Leu24Phe missense_variant 2/85 NM_181303.2 ENSP00000351591.4 Q9NZ94-1
NLGN3ENST00000685718.1 linkuse as main transcriptn.70C>T non_coding_transcript_exon_variant 2/8 ENSP00000510514.1 A0A8I5QJU7

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111934
Hom.:
0
Cov.:
22
AF XY:
0.0000293
AC XY:
1
AN XY:
34080
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000189
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000565
AC:
1
AN:
176976
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
62560
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000370
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
31
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111987
Hom.:
0
Cov.:
22
AF XY:
0.0000293
AC XY:
1
AN XY:
34143
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000188
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 30, 2024The c.70C>T (p.L24F) alteration is located in exon 2 (coding exon 1) of the NLGN3 gene. This alteration results from a C to T substitution at nucleotide position 70, causing the leucine (L) at amino acid position 24 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
.;.;.;T
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.73
T;T;T;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.091
T;T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.3
L;.;L;L
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.82
N;N;N;N
REVEL
Benign
0.16
Sift
Uncertain
0.010
D;D;D;D
Sift4G
Benign
0.073
T;D;T;T
Polyphen
0.0010
.;.;B;.
Vest4
0.19
MutPred
0.73
Loss of catalytic residue at L24 (P = 0.0665);Loss of catalytic residue at L24 (P = 0.0665);Loss of catalytic residue at L24 (P = 0.0665);Loss of catalytic residue at L24 (P = 0.0665);
MVP
0.68
MPC
0.75
ClinPred
0.19
T
GERP RS
3.7
Varity_R
0.24
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs754055025; hg19: chrX-70367669; API